Systems biology-driven drug repurposing in glioblastoma via antigen and pathway mapping
Background and purpose: Glioblastoma (GBM) is an aggressive brain tumor with limited treatment options and poor patient survival. This study aimed to identify key genes and altered pathways in GBM and to explore potential drug-repurposing candidates using a systems biology approach. Experimental approach: We analyzed g...